NCT07561827

Brief Summary

This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB leads to less pain and less need for pain medication after surgery. The ESPB involves an injection of a local anesthetic, ropivacaine, into your child's back muscles to help block pain signals.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at below P25 for phase_3

Timeline
9mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Jun 2025Jan 2027

Study Start

First participant enrolled

June 6, 2025

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 1, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 26, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 26, 2027

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

April 24, 2026

Last Update Submit

April 24, 2026

Conditions

Keywords

posterior spinal fusionpain management

Outcome Measures

Primary Outcomes (3)

  • Compare Oral Morphine Equivalents and Benzodiazepine Doses used in the first 72 hours after surgery among patients who have a ESPB with standard postoperative pain protocols versus those with standard protocols alone.

    Institutional pain management protocol: patients have a hydromorphone patient-controlled analgesia pump until post-operative day 1 and as needed (PO) methadone two times a day, as well as PO oxycodone every 4 hours as needed for moderate pain and IV hydromorphone every 2 hours as needed for severe pain. PO diazepam is available every 6 hours for muscle spasms. The oral morphine equivalents and benzodiazepine doses used in the first 72 hours after surgery will be the primary method of assessing postoperative pain and muscle spasms respectively.

    Change from Baseline to 72 hours after surgery.

  • Evaluate if combining ESPBs with standard postoperative pain protocols reduce postoperative pain scores in the first 24 hours postoperatively as compared to standard protocols alone.

    Pain will be measured on a numerical scale from zero to ten, with zero being no pain at all and ten being the worst pain you have ever felt. Scores will be gathered at multiple time points the day of surgery, and post-op day 1, 2 and 3. We will take the average pain score. These numerical pain scores will be the secondary method of assessing postoperative pain.

    From Baseline to 24 hours after surgery.

  • Assess time to clearance from physical therapy among patients who have a ESPB with standard postoperative pain protocols versus those with standard protocols alone.

    Time to clearance from physical therapy (PT) is a measure that demonstrates the amount of time required to obtain a functional level of mobilization after surgery. This mobilization is often pain limited. For neuromuscular patients with mobility limitations, aim 3 will be measured based on when patients are cleared by PT for safe discharge home. We will measure time to clearance in both groups.

    From postoperative day 1 to physical therapy clearance.

Study Arms (2)

ESPB with Ropivacaine + standard postoperative pain protocol

EXPERIMENTAL

Erector spinae plan block (ESPB) with Ropivacaine and standard postoperative pain protocol

Drug: Ropivacaine Hydrocloride

No ESPB + standard postoperative pain protocol

NO INTERVENTION

No erector spinae plane block (ESPB) or type of injection and standard posteropative pain protocol

Interventions

This drug is approved as a local anesthetic.

ESPB with Ropivacaine + standard postoperative pain protocol

Eligibility Criteria

Age10 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of Adolescent Idiopathic Scoliosis (AIS) or neuromuscular scoliosis
  • Undergoing Posterior Spinal Fusion (PSF) Surgery

You may not qualify if:

  • Patients with forms of scoliosis other than AIS or NM Scoliosis.
  • Patients undergoing a spinal deformity correction surgery other than Posterior Spinal Fusion Surgery
  • Allergy or other contraindication to erector spinae plane block (ESPB) with Ropivacaine patients who are taking pre-operative opioids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Francisco

San Francisco, California, 94158, United States

RECRUITING

Related Publications (9)

  • Chin KJ, Lewis S. Opioid-free Analgesia for Posterior Spinal Fusion Surgery Using Erector Spinae Plane (ESP) Blocks in a Multimodal Anesthetic Regimen. Spine (Phila Pa 1976). 2019 Mar 15;44(6):E379-E383. doi: 10.1097/BRS.0000000000002855.

    PMID: 30180150BACKGROUND
  • Changoor S, Giakas A, Sacks K, Asma A, Lang RS, Yorgova P, Rogers K, Gabos PG, Shah SA. The Role of Liposomal Bupivacaine in Multimodal Pain Management Following Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis: Faster and Farther With Less Opioids. Spine (Phila Pa 1976). 2024 Jan 15;49(2):E11-E16. doi: 10.1097/BRS.0000000000004702. Epub 2023 May 1.

    PMID: 37159268BACKGROUND
  • Akesen S, Guler SB, Akesen B. Bilateral bi-level erector spinae plane blocks in scoliosis surgery: a retrospective comparative study. Acta Orthop Traumatol Turc. 2022 Sep;56(5):327-332. doi: 10.5152/j.aott.2022.22019.

    PMID: 36300557BACKGROUND
  • Tsui BCH, Esfahanian M, Lin C, Policy J, Vorhies J. Moving toward patients being pain- and spasm-free after pediatric scoliosis surgery by using bilateral surgically-placed erector spinae plane catheters. Can J Anaesth. 2020 May;67(5):621-622. doi: 10.1007/s12630-019-01543-0. Epub 2019 Nov 27. No abstract available.

    PMID: 31776896BACKGROUND
  • Diwan SM, Yamak Altinpulluk E, Khurjekar K, Nair A, Dongre H, Turan A. Bilateral erector spinae plane block for scoliosis surgery: Case series. Rev Esp Anestesiol Reanim (Engl Ed). 2020 Mar;67(3):153-158. doi: 10.1016/j.redar.2019.11.012. Epub 2020 Feb 11. English, Spanish.

    PMID: 32057483BACKGROUND
  • Melvin JP, Schrot RJ, Chu GM, Chin KJ. Low thoracic erector spinae plane block for perioperative analgesia in lumbosacral spine surgery: a case series. Can J Anaesth. 2018 Sep;65(9):1057-1065. doi: 10.1007/s12630-018-1145-8. Epub 2018 Apr 27.

    PMID: 29704223BACKGROUND
  • Vergari A, Frassanito L, DI Muro M, Nestorini R, Chierichini A, Rossi M, DI Stasio E. Bilateral lumbar ultrasound-guided erector spinae plane block versus local anesthetic infiltration for perioperative analgesia in lumbar spine surgery: a randomized controlled trial. Minerva Anestesiol. 2022 Jun;88(6):465-471. doi: 10.23736/S0375-9393.22.15950-X. Epub 2022 Feb 22.

    PMID: 35191639BACKGROUND
  • Kendall MC, Alves L, Traill LL, De Oliveira GS. The effect of ultrasound-guided erector spinae plane block on postsurgical pain: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2020 May 1;20(1):99. doi: 10.1186/s12871-020-01016-8.

    PMID: 32357842BACKGROUND
  • Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.

    PMID: 27501016BACKGROUND

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ishaan Swarup, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2026

First Posted

May 1, 2026

Study Start

June 6, 2025

Primary Completion (Estimated)

January 26, 2027

Study Completion (Estimated)

January 26, 2027

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations